Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 377

1.

Docosahexaenoic acid restores endothelial function in children with hyperlipidemia: results from the EARLY study.

Engler MM, Engler MB, Malloy M, Chiu E, Besio D, Paul S, Stuehlinger M, Morrow J, Ridker P, Rifai N, Mietus-Snyder M.

Int J Clin Pharmacol Ther. 2004 Dec;42(12):672-9.

PMID:
15624283
2.
3.

Effects of docosahexaenoic acid on serum lipoproteins in patients with combined hyperlipidemia: a randomized, double-blind, placebo-controlled trial.

Davidson MH, Maki KC, Kalkowski J, Schaefer EJ, Torri SA, Drennan KB.

J Am Coll Nutr. 1997 Jun;16(3):236-43.

PMID:
9176830
4.
5.

Cholesterylestertransfer protein inhibition and endothelial function in type II hyperlipidemia.

Hermann F, Enseleit F, Spieker LE, Périat D, Sudano I, Hermann M, Corti R, Noll G, Ruschitzka F, Lüscher TF.

Thromb Res. 2009;123(3):460-5. doi: 10.1016/j.thromres.2008.06.022. Epub 2008 Sep 11.

PMID:
18789492
6.
7.

Early statin therapy restores endothelial function in children with familial hypercholesterolemia.

de Jongh S, Lilien MR, op't Roodt J, Stroes ES, Bakker HD, Kastelein JJ.

J Am Coll Cardiol. 2002 Dec 18;40(12):2117-21.

8.

Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial.

Engler MM, Engler MB, Malloy MJ, Chiu EY, Schloetter MC, Paul SM, Stuehlinger M, Lin KY, Cooke JP, Morrow JD, Ridker PM, Rifai N, Miller E, Witztum JL, Mietus-Snyder M.

Circulation. 2003 Sep 2;108(9):1059-63. Epub 2003 Aug 11.

9.

Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men.

Kelley DS, Siegel D, Vemuri M, Mackey BE.

Am J Clin Nutr. 2007 Aug;86(2):324-33.

10.

Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia.

Lu TM, Ding YA, Leu HB, Yin WH, Sheu WH, Chu KM.

Am J Cardiol. 2004 Jul 15;94(2):157-61.

PMID:
15246890
11.

Effect of docosahexaenoic acid on lipoprotein subclasses in hyperlipidemic children (the EARLY study).

Engler MM, Engler MB, Malloy MJ, Paul SM, Kulkarni KR, Mietus-Snyder ML.

Am J Cardiol. 2005 Apr 1;95(7):869-71.

PMID:
15781019
13.

An omega-3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia.

Calabresi L, Villa B, Canavesi M, Sirtori CR, James RW, Bernini F, Franceschini G.

Metabolism. 2004 Feb;53(2):153-8.

PMID:
14767865
14.
15.

Ciprofibrate treatment decreases non-high density lipoprotein cholesterol and triglycerides and increases high density lipoprotein cholesterol in patients with Frederickson type IV dyslipidemia phenotype.

Bermúdez-Pirela V, Souki A, Cano-Ponce C, Bermúdez-Arias F, Mengual-Moreno E, Leal-Gonzalez E, Lemus-Antepaz M, de Bravo MC, de Díaz AA, de Pirela NL, Cano-Peñaloza R, Puche-Medina G, Arraiz N, Reyna-Villazmil N, Contreras F, Israili ZH, Valasco M.

Am J Ther. 2007 Mar-Apr;14(2):213-20.

PMID:
17414592
16.

Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects.

Mori TA, Woodman RJ, Burke V, Puddey IB, Croft KD, Beilin LJ.

Free Radic Biol Med. 2003 Oct 1;35(7):772-81.

PMID:
14583341
17.

Randomized crossover study of gemfibrozil versus lovastatin in familial combined hyperlipidemia: additive effects of combination treatment on lipid regulation.

Zambón D, Ros E, Rodriguez-Villar C, Laguna JC, Vázquez M, Sanllehy C, Casals E, Sol JM, Hernández G.

Metabolism. 1999 Jan;48(1):47-54.

PMID:
9920144
18.
19.

Lipoprotein response to a National Cholesterol Education Program step II diet with and without energy restriction.

Flynn MM, Zmuda JM, Milosavljevic D, Caldwell MJ, Herbert PN.

Metabolism. 1999 Jul;48(7):822-6.

PMID:
10421219
20.

Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults.

Clarkson P, Adams MR, Powe AJ, Donald AE, McCredie R, Robinson J, McCarthy SN, Keech A, Celermajer DS, Deanfield JE.

J Clin Invest. 1996 Apr 15;97(8):1989-94.

Supplemental Content

Support Center